Marc F Schwartz

Title: The Innovations of Marc F. Schwartz

Introduction

Marc F. Schwartz is an accomplished inventor based in West Windsor, NJ, USA. With a robust portfolio of three patents, he has significantly contributed to the field of biotechnology, particularly in the production and modification of therapeutic proteins.

Latest Patents

One of his latest patents is focused on the "Expression of O-glycosylated therapeutic proteins in prokaryotic microorganisms." This invention relates to innovative methods for producing O-glycosylated soluble therapeutic proteins by co-expressing both the therapeutic protein and a heterologous glycosyltransferase that facilitates the transfer of sugar moieties to specific amino acid acceptors on the protein.

Another significant patent is titled "Expression of soluble, active eukaryotic glycosyltransferases in prokaryotic organisms." This invention provides improved methodologies for producing soluble and functional eukaryotic glycosyltransferases in prokaryotic microorganisms that exist in oxidizing environments. These advancements have critical implications for the development of therapeutic proteins.

Career Highlights

Marc has gained extensive experience by working with prominent companies, including Biogenerix AG and Biogenerix GmbH. His work in these organizations has allowed him to develop expertise in biotechnology and innovative protein production strategies.

Collaborations

Throughout his career, Marc has collaborated with talented individuals such as Shawn DeFrees and Karl Frank Johnson. These collaborations have fostered an environment of innovation and discovery, facilitating the progress of their projects and inventions.

Conclusion

Marc F. Schwartz's contributions to the field of biotechnology through his patents are noteworthy. His inventive approaches to the production of therapeutic proteins highlight his dedication to advancing medical science and improving human health. With a commitment to innovation, Marc continues to make strides in biotechnology that benefit both the industry and society.